Dr. Abdelhakim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Shawnee Mission Pkwy Ste 210
KU Cancer Center Mailstop 5003
Westwood, KS 66205Phone+1 913-588-0348Fax+1 913-588-4085
Education & Training
- University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
- University of Kansas School of MedicineResidency, Internal Medicine, 2013 - 2016
- Zagazig University Faculty of MedicineClass of 2010
Certifications & Licensure
- KS State Medical License 2020 - 2025
- MO State Medical License 2022 - 2025
- OH State Medical License 2014 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- The multifaceted roles of extracellular vesicles for therapeutic intervention with non-Hodgkin lymphoma.Arthur A Lee, Andrew K Godwin, Haitham Abdelhakim
Extracellular Vesicles and Circulating Nucleic Acids. 2024-06-01 - Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.Matthew McGuirk, Moazzam Shahzad, Muhammad Kashif Amin, Muhammad Atif Khan, Polina Bellman
Transplant Immunology. 2024-06-01 - Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis.Moazzam Shahzad, Qamar Iqbal, Ezza Tariq, Mohammad Ammad-Ud-Din, Atif Butt
Critical Reviews in Oncology/hematology. 2024-04-01
Lectures
- Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: